A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Total Knee Arthroplasty
Phase of Trial: Phase II
Latest Information Update: 05 May 2007
At a glance
- Drugs Capsaicin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors AlgoRx Pharmaceuticals
- 05 May 2007 Results have been reported.
- 01 Aug 2006 Status change
- 18 Dec 2005 New trial record.